Glenmark Pharmaceuticals has closed its trading window for dealing in securities effective October 1, 2026. The closure will remain in force until 48 hours after the company declares its unaudited financial results for the second quarter ended September 30, 2026.

This action is taken pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct. The restriction applies to Designated Persons, including Directors, Key Managerial Personnel, Identified Employees, their immediate relatives, and Connected Persons.

Scope of the Trading Ban

The trading window closure is a standard compliance measure to prevent insider trading during the sensitive period leading up to earnings announcements. During this time, the specified individuals are prohibited from buying or selling the company's shares.

Upcoming Board Meeting

The date for the Board Meeting to approve the standalone and consolidated financial results will be intimated separately. The company has confirmed that this intimation is also available on its official website.

Glenmark Pharmaceuticals shares worth ₹37.28 crore were flagged by a real-time trade-scanning system after approximately 1,50,735 shares changed hands on the NSE at a price of ₹2,473.00 per share.

This is a real-time large-trade signal, not a confirmed block or bulk deal. NSE/BSE publish official block and bulk deal reports only after market close — this trade may or may not appear there.

Large-trade signal details

The following table summarises the key parameters of the flagged activity:

What the signal reflects

This alert was generated by a real-time trade-scanning system that identified a cluster of trades in Glenmark Pharmaceuticals printing at or near ₹2,473.00 within a short window, flagged for their combined size and speed. The signal does not identify any buyer, seller, broker, or client — that information, if applicable, would only become available through official exchange disclosures after market close.

The activity highlighted in this report is an intraday market signal and should not be interpreted as an NSE-reported bulk or block deal. Official bulk and block deal information is separately disclosed by the exchange.

What this is, and isn't: this reflects trade-level activity — a cluster of trades in the stock above, printed within a short window at or near the quoted price, for a combined value as stated. It is generated by our real-time trade-scanning system and is not, by itself, evidence of a block or bulk deal.

A block deal has to be executed in the exchange's dedicated window (8:45–9:00am or 2:05–2:20pm), within a set price band, and above the current minimum order size (₹25 crore). A bulk deal is when one client's total trading in a stock crosses 0.5% of its equity in a single day — confirmed only once every trade that client made is added up.

Both are published by NSE/BSE after trading hours end, typically after 3:30pm — never before. If this trade qualifies as either, it will appear in the exchange's own report later today, not here first.